SARS-CoV-2 Spike S1 Subunit Triggers Pericyte and Microvascular Dysfunction in Human Pancreatic Islets
Diabetes · 2025
DOI: 10.2337/db24-0816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2025. Verfasst von Catarina Andrade Barboza und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL. Hauptthemen laut MEDLINE: Pericytes, Islets of Langerhans, Spike Glycoprotein, Coronavirus, SARS-CoV-2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Division of Diabetes, Endocrinology, and Metabolic Diseases, JDRF.
Abstract (Originalsprache)
The COVID-19 pandemic has profoundly affected human health; however, the mechanisms underlying its impact on metabolic and vascular systems remain incompletely understood. Clinical evidence suggests that SARS-CoV-2 directly disrupts vascular homeostasis, with perfusion abnormalities observed in various tissues. The pancreatic islet, a key endocrine miniorgan reliant on its microvasculature for optimal function, may be particularly vulnerable. Studies have proposed a link between SARS-CoV-2 infection and islet dysfunction, but the mechanisms remain unclear. Here, we investigated how SARS-CoV-2 spike S1 protein affects human islet microvascular function. Using confocal microscopy and living pancreas slices from organ donors without diabetes, we show that a SARS-CoV-2 spike S1 recombinant protein activates pericytes, key regulators of islet capillary diameter and β-cell function, and induces capillary constriction. These effects are driven by a loss of ACE2 from pericytes’ plasma membrane, impairing ACE2 activity and increasing local angiotensin II levels. Our findings highlight islet pericyte dysfunction as a potential contributor to the diabetogenic effects of SARS-CoV-2 and offer new insights into the mechanisms linking COVID-19, vascular dysfunction, and diabetes. Article Highlights Different components of the renin-angiotensin system are expressed by vascular cells in human pancreatic islets. The islet microvasculature is responsive to vasoactive angiotensin peptides. This pancreatic renin-angiotensin system is targeted upon incubation with a SARS-CoV-2 spike recombinant protein. SARS-CoV-2 spike activates pericytes and constricts capillaries in human islets. Islet vascular dysfunction could contribute to dysglycemia in some patients with COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.
- Department of Physiology and Biophysics, University of Miami Miller School of Medicine, Miami, FL.
- Diabetes Research Institute, University of Miami Health System, Miami, FL.
- Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL.
ORCID-Profile: Joana Almaça
Förderung
- NIDDK NIH HHS
- Division of Diabetes, Endocrinology, and Metabolic Diseases
- JDRF
- Leona M. and Harry B. Helmsley Charitable Trust
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Andrade Barboza, C., Gonçalves, L. M., Pereira, E., Cruz, R. D., Andrade Louzada, R., Boulina, M., & Almaça, J. (2025). SARS-CoV-2 Spike S1 Subunit Triggers Pericyte and Microvascular Dysfunction in Human Pancreatic Islets. Diabetes. https://doi.org/10.2337/db24-0816
Vancouver
Andrade Barboza C, Gonçalves LM, Pereira E, Cruz RD, Andrade Louzada R, Boulina M, et al. SARS-CoV-2 Spike S1 Subunit Triggers Pericyte and Microvascular Dysfunction in Human Pancreatic Islets. Diabetes. 2025. doi:10.2337/db24-0816
BibTeX
@article{AndradeBarboza2025,
author = {Andrade Barboza, Catarina and Gonçalves, Luciana Mateus and Pereira, Elizabeth and Cruz, Roxana Diaz and Andrade Louzada, Ruy and Boulina, Maria and Almaça, Joana},
title = {SARS-CoV-2 Spike S1 Subunit Triggers Pericyte and Microvascular Dysfunction in Human Pancreatic Islets},
journal = {Diabetes},
year = {2025},
doi = {10.2337/db24-0816}
}
EUVIMED